Skip to main content
VCbacked
Log inGet Started

Ascendia Pharmaceuticals

North Brunswick, United States

Ascendia Pharmaceuticals offers a comprehensive suite of pre-formulation for preclinical- and clinical-stage drug candidates.

$2.5M raised
Jun 2025
Venture - Series Unknown
BiotechnologyHealth CarePharmaceutical

Top Investors

Signet Healthcare Partners

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Ascendia Pharmaceuticals

How much funding has Ascendia Pharmaceuticals raised?
Ascendia Pharmaceuticals has raised $2.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2025.
Who are Ascendia Pharmaceuticals's investors?
Ascendia Pharmaceuticals's investors include Signet Healthcare Partners.
Where is Ascendia Pharmaceuticals headquartered?
Ascendia Pharmaceuticals is headquartered in North Brunswick, United States.
What does Ascendia Pharmaceuticals do?
Ascendia Pharmaceuticals offers a comprehensive suite of pre-formulation for preclinical- and clinical-stage drug candidates.
What stage is Ascendia Pharmaceuticals at?
Ascendia Pharmaceuticals is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Ascendia Pharmaceuticals — Funding & Investors." VCBacked, June 4, 2025, https://www.vcbacked.co/company/ascendia-pharmaceuticals. Accessed July 2, 2026.
APA
VCBacked. (2025). Ascendia Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/ascendia-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Ascendia Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/ascendia-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K